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ABSTRACT
Objectives: Service and stakeholder evaluation of an
NHS-funded service providing out-ofhours (OOH)
emergency repeat medications to patients self-
presenting at community pharmacies.
Setting: Community pharmacies across the North East
of England accredited to provide this service.
Participants: Patients self-presenting to community
pharmacies during OOH periods with emergency repeat
medication supply requests.
Intervention: Community pharmacists assessed each
request for clinical appropriateness and when suitable
provide an emergency repeat medication supply, with
additional pharmaceutical advice and services if
required.
Primary outcomes: Number of emergency repeat
medication supplies, time of request, reason for
access, medication(s), pharmaceutical advice and
services provided. Secondary outcomes were
community pharmacist and patient satisfaction.
Results: A total of 2485 patients were managed
across 227 community pharmacies (15 December
2014 to 7 April 2015). Most patients presented on
Saturdays, with increased activity over national
holidays. Older age was associated with increased
service use. Of the 3226 medications provided, 439
were classified as high risk. Patients found this service
easy to access and were willing to access the
community pharmacy in the future for medication-
related issues. In the absence of this service, 50% of
patients would have missed their medication(s) until
they saw their doctor and a further 46% would have
accessed an alternative service. The cost of National
Health Service (NHS) service(s) for patients who would
have accessed an alternative OOH service was
estimated as 37 times that of the community pharmacy
service provided. Community pharmacists were happy
to provide this service despite increased consultation
times and workload.
Conclusions: Community pharmacists were able to
manage patients’ OOH requests for emergency repeat
medication and patients were happy with the service
provided. Since the service cost was favourable when
compared with alternative OOH services, it would be a
viable option to reduce the workload on the wider
NHS.
INTRODUCTION
National Health Service (NHS) 111 is a free
to call number available 24 h a day, 7 days a
Strengths and limitations of this study
▪ This study suggests that a National Health
Service (NHS)-funded emergency repeat medica-
tion supply service from community pharmacies
reduces the workload on other NHS out-of-hours
emergency care providers and is well received by
both self-presenting patients and participating
community pharmacists.
▪ This study suggests that provision of this out-of-
hours service from community pharmacies was
less costly when compared with the alternative
emergency care providers which patients may
have accessed to obtain an emergency supply of
their medication if this service had been
unavailable.
▪ Patient feedback was not linked to their respect-
ive individual service information, so patient
safety issues caused by non-adherence of high-
risk medications could not be determined.
▪ Patients were not informed of the full cost of
their specific emergency repeat medication
supply request when asked if they were willing to
pay for an emergency supply of repeat medica-
tion by a community pharmacist.
▪ Patients were asked what action they would have
undertaken to obtain their medication if the
National Health Service (NHS)-funded emergency
repeat supply service had not been available.
Information about the actions of patients who
were not provided with medication was not cap-
tured in this study.
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week, 365 days a year to respond to people’s healthcare
needs and enable access to non-urgent NHS care.1 2
Recent national press coverage, particularly during
winter 2014–2015,3 reported considerable demand for
urgent care services. This was as predicted by Turner
et al4 in their study of NHS 111 pilot sites. In December
2014, NHS England reported the largest volume of calls
(1 398 166) since the phone line was established.5 Up to
15% of calls relate to emergency repeat medication at
busy times, for example, bank holidays, national holi-
days, or out of hours (OOH) and at the weekends. On
bank holidays, 3–4% of appointments with general prac-
titioner (GP) OOH were for prescriptions for repeat
medicines.6
Under the Human Medicines Regulations community,
pharmacists are legally permitted to provide emergency
supplies of prescription only medicines (POMs) at the
request of the patient without a prescription.7
Pharmacists use their professional judgement on a
case-by-case basis to ensure that such a supply is clinic-
ally appropriate and all stipulated regulations have been
met. The cost of an emergency supply of POMs for
patients exempt from prescription charges means they
often choose to access an OOH service or emergency
department if they consider their medicine request is
urgent. Visitors away from their place of residence may
also present with requests for forgotten or short supplies
of medication.8
NHS England has supported local health commis-
sioners to mobilise capacity within community pharmacy
to help relieve pressures on emergency and urgent care.
They stated that community pharmacies can be commis-
sioned, where appropriate, to provide an emergency
supply of medicines as an NHS-funded service. NHS
England stipulates that legal requirements should be
met and that the patient’s GP must be notiﬁed of such a
supply within 48 h.6 9 The topic of the NHS England
agreed audit for 2014–2015 was that of emergency
supply of medicines. Community pharmacists were asked
to audit their activity of this activity during speciﬁc
periods in 2015. This audit was planned to provide data
to inform the review of urgent and emergency care and
demonstrate how community pharmacy might best work
with GP practices to improve services to patients.10
Findings from this audit are still to be reported.
Research over the past 10 years about emergency
supply of medicines has primarily focused on the fre-
quency and characteristics of emergency supplies or the
ethical perspective of patients who present with such
requests.8 A recent evaluation also stated that no
national NHS was in place in England to manage
requests for emergency supplies, although some loca-
lised services did exist. The authors recommended the
establishment of a national NHS-funded service to allow
community pharmacists to provide regularly prescribed
medicines to NHS patients under the existing provisions.
The intended impact would be to reduce the workload
on the wider NHS.8 Since 2011, NHS Cornwall and Isles
of Scilly has provided a walk-in repeat medication service
from community pharmacies using a Patient Group
Direction (PGD) to deliver an NHS during summer
periods. Currently, there is a locally commissioned
service in Cornwall to provide emergency supplies
OOH.11 In West Yorkshire, the NHS 111 provider,
Yorkshire Ambulance Service, can refer urgent repeat
medication requests directly to local pharmacies using
NHS Mail as the referral platform.12
In November 2014, NHS England North, working
across Cumbria and the North East and supported by
local Clinical Commissioning Groups (CCG), commis-
sioned an NHS Community Pharmacy Emergency
Repeat Medication Supply Service (PERMSS) as a pilot
over 4 months. The purpose of this scheme was to
ensure that patients had access to a supply of their
regular prescription medicines when they were unable
to obtain a prescription before they needed to take their
next dose. The service proposal was ﬁnalised by a
project team with members from the Local Pharmacy
Network (LPN), Commissioning Support Unit 111
Directory of Service and NHS England. A non-recurrent
funding source was established and presented to the
CCG forum for commissioning for the pilot period (15
December 2014 to 7 April 2015). The service speciﬁca-
tion13 was circulated to all community pharmacies
(n=711) across the North East. An information sheet of
Frequently Asked Questions was disseminated to all con-
ﬁrmed, eligible community pharmacy providers. A short
period of testing preceded the service launch.
Patients could access this service at two entry points,
either direct referral from NHS 111 using a referral plat-
form, PharmOutcomes, a web-based system collating
information and facilitating management of local service
provision which is currently being used by all community
pharmacies across the North East,14 or by self-
presentation out of normal GP opening times at a com-
munity pharmacy. This study aimed to evaluate the
Community PERMSS for those patients who self-
presented at community pharmacies out of normal GP
opening times. Speciﬁcally, service activity will be evalu-
ated along with the feedback on the service from
the patients accessing and community pharmacists pro-
viding it.
Service intervention for self-presenting patients
The commissioned PERMSS allowed community phar-
macists to provide up to a 7-day supply of the patient’s
POM, except where it was not possible to dispense such
volumes, for example, inhalers, creams. In such cases,
the smallest pack size was dispensed. However, the regu-
lations prevent schedule 1, 2 or 3 controlled drugs being
supplied in an emergency with the exception of pheno-
barbitone or phenobarbitone sodium prescribed for epi-
lepsy. Patients who were exempt from prescription
charges received the medicine supply free of charge,
while those patients who were not exempt paid the
standard prescription charge (£8.20). A professional fee
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linked to the number of items supplied (£10+£2 for
each additional item) together with reimbursement of
the cost of the medicine (Drug Tariff prices plus VAT)
was paid for each emergency supply consultation.
The patient or their representative presented at a
community pharmacy during the OOH period. This was
deﬁned as Monday to Friday between 18.30 and 8:00,
weekends (18:30 Friday to 8:00 Monday), Christmas Eve
and New Year’s Eve between 18:00 and 8:00 and at any
time on speciﬁed days (Christmas Day, Boxing Day, New
Year’s Day, Easter Friday and Easter Monday).
The community pharmacist assessed whether there
was an urgent need for the medicine checking where it
was impracticable for the patient to obtain a prescription
before the next dose was due. This was followed by one
of three outcomes:
▸ An emergency supply was made, in accordance with
the Human Regulations 2012,7 as no further clinical
advice was required and the POM was available in the
community pharmacy;
▸ The patient was advised to try another pharmacy
because, although no further clinical advice was
required, the POM was unavailable at the community
pharmacy;
▸ The patient was advised to contact another appropri-
ate healthcare service, for example, NHS 111 or a
walk-in centre because further clinical advice was
needed.
When an emergency supply was made, the supply was
recorded in accordance with the usual procedure. A
record of this supply was also made in PharmOutcomes,
detailing the patient’s name, address, verbal consent for
supply, medication supplied, nature of emergency, evi-
dence provided and if further pharmaceutical services
and advice was needed. A copy of the record was sent to
the patient’s GP using the PharmOutcomes email notiﬁ-
cation facility. This included any relevant concerns,
advisory notes or issues identiﬁed. Further patient
pharmaceutical advice could have consisted of effective
medicines management, prescription request process
and/or medicines reconciliation. Additional services
which could also have been provided were a Medicines
Use Review (MUR) or consent obtained for repeat
dispensing.
METHODS
Service activity
Service activity, with patient identiﬁable information
removed, was automatically sent to the independent
evaluator (HN) as an Excel spreadsheet via email from
PharmOutcomes. However, the patient’s age and post-
code were included in this data set. The frequency in
self-presentation activity across each month and also
across the days of the week was investigated to identify
any increase in demand at speciﬁc periods. Reasons for
an emergency supply request and evidence to support
this were extracted. Drugs supplied under this service
were categorised according to the British National
Formulary (BNF 68).15 Supply of high-risk drugs as iden-
tiﬁed by the Patient Safety First Campaign 2008,16
opiates, insulin, anticoagulants, antipsychotics, non-
steroidal anti-inﬂammatories (NSAIDs) and diuretics
were also collated. The number and nature of additional
pharmaceutical advice or services were extracted.
Patient feedback
The patient survey was designed to obtain feedback on
the service. Patients were asked what their action might
have been if this service had not been available; they
were also asked that if this service was associated with a
cost, would their action have changed and, if so, in what
way. Patients were asked to rate the PERMSS in compari-
son to other OOH services and also to rate their general
satisfaction with the service provided. This survey was
designed by the project team and disseminated to the
local HealthWatch group and LPN to test for face valid-
ity. We were provided with feedback on format, compre-
hensiveness and appropriateness of the questions before
being used with patients.
At the end of the study period, the collected anon-
ymised patient feedback was sent as an Excel spread-
sheet to the independent evaluator (HN) by email from
PharmOutcomes.
Community pharmacist feedback
An electronic questionnaire was also designed by the
project team and circulated within the local
HealthWatch group and the LPN to again test for face
validity. Respondents were asked for comment and
approval. This semi-structured questionnaire was
designed to evaluate the community pharmacists’ under-
standing and support of the service. In addition, phar-
macists were asked if requests for an emergency supply
of medicines should be managed by community phar-
macists and how well this service aligned with their
current role and responsibilities. Pharmacists were also
asked about how this service contributed to the work-
load, impact on consultation time, and their satisfaction
with the reimbursement process. Finally, pharmacists
were asked how supportive they were to provide such a
service and if service improvements were required.
This electronic survey was circulated via
PharmOutcomes between 5 January and 7 April 2015.
An email message from the Local Pharmacy Committees
to alert pharmacists to complete the survey was sent on
5 January. At the end of the evaluation period, the anon-
ymised community pharmacist feedback was sent as an
Excel spreadsheet to the independent evaluator (HN)
by email from PharmOutcomes.
Data analysis
Data relating to service activity and from the patient and
pharmacist surveys were analysed using descriptive statis-
tics and converted to percentages where appropriate to
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represent proportions. Open comments were manually
coded from both surveys.
Cost comparison of PERMSS to existing OOH services
A cost comparison was carried out; however, as health
beneﬁts were not included, a comparative evaluation of
costs and beneﬁts, for example, cost-effectiveness or cost-
beneﬁt analysis, was not performed. The costs of the
community pharmacy provisions of emergency supplies
were compared with the costs which could have been
incurred should the patient have accessed other OOH
services. The costs for an individual consultation at acci-
dent and emergency (A&E) department, urgent centre
and walk-in centres were provided by the North of
England Commissioning Support Unit based on locally
derived data. The GP OOH service was a block contract
with no individual cost per consultation. So an estimated
cost per individual consultation was calculated by divid-
ing the cost of the block contract by the activity within
the region provided by the North of England
Commissioning Support Unit.
The patients’ responses regarding which service they
would have accessed in the absence of PERMSS were
used to calculate the potential costs for the evaluation
period and also projected annual cost. A number of
patients indicated that they would have called NHS 111,
with a £8 cost per call.4 NHS 111 would then direct such
patients to GP OOH service incurring an additional
cost.
Discussion within the project team and on consult-
ation of the NHS Health Research Authority guidance17
identiﬁed the study components to be either audit or
service evaluation and therefore ethical approval was not
required.
RESULTS
Service activity
The service was provided in 227 of the accredited 316
pharmacies across the 12 participating CCGs. In total,
2485 patients self-presented over the evaluation period.
This equates to approximately three patients being
managed per pharmacy per month. Table 1 shows the
characteristics of the patients who presented and the
nature of the emergency supply requested.
These 2485 patients were supplied with 3226
medicines, the classiﬁcations of which are described in
table 2.
Patient feedback
A 60.8% response rate was obtained with 1511 of the
2485 self-presenting patients providing responses to the
questionnaire. Compared to other NHS OOH services,
93% (n=1405) of respondents found this service easier
or much easier to access, and all (100%) respondents
would use the community pharmacy in the future for
medication issues. Patients were also questioned about
what their action might have been in the absence of
such a community pharmacy service, and also their
action if this service had an associated cost (table 3).
If the PERMSS had not existed, half (50%, n=756) of
the respondents suggested that they would have missed
their dose(s) until their GP was available to obtain a
Table 1 Characteristics of patients requiring an
emergency supply, the nature of that emergency and
evidence to prove previous medicine supply (n=2485)
Characteristics of emergency supply
request
Number
(%)
Access by month
December 2014 (15–31) 344 (13.8)
January 2015 (1–31) 651 (29.2)
February 2015 (1–28) 550 (22.1)
March 2015 (1–31) 534 (21.5)
April 2015 (1–7) 406 (16.3)
Access by day
Sunday 212 (8.5)
Monday 119 (4.8)
Tuesday 67 (2.7)
Wednesday 54 (2.2)
Thursday 78 (3.1)
Friday 140 (5.6)
Saturday 1815 (73.0)
Age of patient (years)
<13 96 (3.9)
13–19 69 (1.8)
20–29 194 (7.8)
30–39 213 (8.6)
40–49 306 (12.3)
50–59 437 (17.6)
60–69 466 (18.8)
≥70 704 (28.3)
Reason for emergency supply request
Ran out of medicines 1308 (81.6)
Prescription not ready at the GP surgery 221 (13.8)
Away from home without medicine(s) 69 (4.3)
GP surgery closed 42 (2.6)
Other 155 (9.7)
Evidence of repeat medicines
Prescription request form 393 (15.8)
Empty pack 455 (18.3)
Patient medication record 1464 (58.9)
GP letter 15 (0.6)
Other 158 (6.4)
Levy status
Exempt 2249 (90.5)
Paid prescription charge 236 (9.5)
Additional pharmaceutical advice provided
Effective medicines management 1216 (48.9)
Medicines reconciliation 1364 (54.9)
Prescription request process 249 (10.0)
Other 197 (7.9)
Additional pharmaceutical service provided
Medicines Use Review 52 (2.1)
Repeat dispensing consent 48 (2.3)
None necessary 2322 (93.4)
Other 67 (2.7)
GP, general practitioner.
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prescription. A further 46% (n=695) would have
accessed another OOH service. There were 60 patients
who indicated that they would have undertaken an alter-
native action which included: have purchased an alterna-
tive ‘over-the-counter’ medication(n=6); gone to a
different pharmacy (n=10); used a friend’s or family
member’s medicine (n=11); returned home to retrieve
the medicines (n=12); waited to see if they could
manage without and then accessed another OOH
service (n=5); or asked a neighbour to post medication
(n=5). Eleven people did not answer this question. If an
emergency supply service did exist but the patient had
to pay for the prescription, the majority (61%, n=921) of
patients indicated that they would have paid for their
medication, while a smaller number suggested that they
would have missed the dose(s) (19%, n=287) or
accessed another OOH service (18%, n=272).
Community pharmacist feedback
Of the 316 community pharmacists who were accredited
to undertake this service, 221 completed the question-
naire (70% response rate). The service had been pro-
vided to self-presenting patients OOH by pharmacists at
153 (69%) community pharmacies.
Of the respondents, 91% (n=201) agreed or strongly
agreed that they were clear on the remit and terms of
the service, and agreed or strongly agreed (91%, n=201)
that the service was aligned with their current role. The
management of requests for an emergency supply of
medicines OOH by community pharmacists was consid-
ered appropriate with 94% (n=208) of pharmacists in
agreement.
Pharmacists (84%, n=186) agreed or strongly agreed
that they were clear on when to claim for the service
provided and 70% (n=155) agreed or strongly agreed
that the reimbursement process was simple.
Many of the community pharmacists (66%, n=146)
reported an increase in consultation time and identiﬁed
additional workload. However, the community pharma-
cists were happy or very happy to provide this service to
self-presenting patients (92%, n=203). However, when
asked how the service could be improved, while 25%
(n=55) disagreed or strongly disagreed that changes
were required, 40% (n=88) identiﬁed improvements. Of
those who made suggestions for improvement (n=20),
17 pharmacists suggested refresher training for pharma-
cists on the emergency supply regulations, and three
pharmacists recommended an increase in pharmacy cap-
acity to manage these patient requests.
Cost comparison
Of the 1511 self-presenting patients who provided feed-
back, 695 stated that they would have accessed an alter-
native OOH service had the PERMSS not been available.
Table 2 Medicines supplied through Pharmacy
Emergency Repeat Medication Supply Service (PERMSS)
as per the British National Formulary (BNF) 68
classification and the distribution of key high-risk drugs
Classification of medicine
Number (%)
(n=3226)
BNF classification
Cardiovascular 1122 (34.8)
Central nervous system 646 (20.0)
Respiratory 467 (14.5)
Endocrine 429 (13.3)
Gastrointestinal 223 (6.9)
Obstetrics, gynaecology and urinary 102 (3.2)
Musculoskeletal 70 (2.2)
Skin 22 (0.7)
Nutrition and blood 34 (1.1)
Infections 28 (0.9)
Malignancies 36 (1.1)
Eye 37 (1.1)
Ear, nose and oropharynx 10 (0.3)
High-risk categories (n=439, 13.6%)
Opiates 53 (1.6)
Insulin 61 (1.9)
Anticoagulants 149 (4.6)
Antipsychotics 40 (1.2)
Non-steroidal anti-inflammatories 37 (1.1)
Diuretics 99 (3.1)
Table 3 Patients’ reported actions in the absence of PERMSS or if a service had been available but was associated with a
cost (n=1511)
Criteria Action Number (%)
Action if unable to obtain
medicine from the pharmacist
Missed dose(s) and presented at the GP surgery during surgery hours 756 (50.0)
Presented at the walk-in centre or urgent care centre 499 (33.0)
Presented at accident and emergency 166 (11.0)
Called NHS 111 30 (2.0)
Other 60 (4.0)
Action if required to pay for
the medicine
Paid for emergency supply 921 (61.0)
Missed dose(s) and presented at the GP surgery during surgery hours 287 (19.0)
Presented at the walk-in centre or urgent care centre 212 (14.0)
Presented at accident and emergency 60 (4.0)
Called NHS 111 30 (2.0)
Other 1 (0.0)
GP, general practitioner; NHS, National Health Service; PERMSS, Pharmacy Emergency Repeat Medication Supply Service.
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Each patient received an average of 1.58 medications,
and therefore the average PERMSS cost was £11.16. For
the 695 patients, the cost in reimbursement to the com-
munity pharmacist for the consultation was estimated to
be £1098.10. The projected annual cost of PERMSS
would be £3294.30. The estimated cost of the alternative
service access is shown in table 4.
During the evaluation period, if alternative OOH ser-
vices had been accessed in place of PERMSS, this could
have been associated with an estimated cost of £41 025,
37 times the cost for supplies made via PERMSS.
DISCUSSION
This service addresses one of the key recommendations
for practice in the evaluation of the role of community
pharmacists in managing requests for emergency sup-
plies made by Morecroft et al8 This recommendation has
also been recently reiterated in the national pharma-
ceutical press as a strategy to reduce pressure on the
NHS.18 PERMSS is an NHS-funded service allowing
pharmacists to supply regularly prescribed medicines to
NHS patients under the existing Regulations. The
service also includes additional features to support
patients managing their medicines more effectively and
giving the community pharmacist an opportunity to
provide additional services, such as medicines reconcili-
ation or an MUR to optimise medicines use when
required. This evaluation demonstrated that patients are
now happy to have medication issues managed by a com-
munity pharmacist and ﬁnd accessibility much easier
than alternative OOH services. Tinelli et al also report
high patient satisfaction with a pharmacy-led medica-
tions management service. This represented a shift from
a previous preference for a doctor-led discussion prior
to experiencing the service within the pharmacy.19 This
service evaluation also reiterates ﬁndings from
Morecroft et al8 that indicate that community pharma-
cists provide an important and under-recognised service
for patients to ensure sustained treatment supporting
medication adherence and decrease the overall burden
on the wider NHS.
Supplies were made during OOH periods and the
volume of activity from 1 to 7 April indicated that a
holiday, including a bank holiday, increased the
numbers in requests, as has been previously recorded.6
However, this evaluation estimated that on average only
three patients were managed per pharmacy per month,
which does not demonstrate a high demand for this
service. This is maybe an underestimation because
although emergency supplies of POMs at the request of
a patient is an activity that every pharmacist is familiar
with, they are not routinely required to complete a
record on PharmOutcomes. Emergency supply records
are made most commonly within the patient medication
record and/or in the private prescription record.
Consequently, some supplies may have been made which
were not captured, as details of supply were not
recorded in PharmOutcomes. Although there was a
trend towards more requests from older patients
(>60 years old), there were signiﬁcant numbers from the
young (<30 years old) and middle-aged (30–60 years
old). A recent review of the role of community pharma-
cists in emergency supply requests found similar results
and suggested that older people may have more difﬁcul-
ties in ordering their repeat prescriptions on time, all
the more so because this patient group has more medi-
cations.8 The main reason for the emergency supply
request was that the patient had run out. The patient’s
medication record was the most common source of evi-
dence that was used to verify that the medication was
one that the patient received on repeat. This would indi-
cate that patients presented at their regular community
pharmacy as their medication records were available and
accessed. However, we have no information about
whether they were registered on a repeat prescription
service since this was not an aim of the study and is not
information routinely recorded in PharmOutcomes or
necessarily on a patient’s medication history. The most
common medications supplied to self-presenting
patients were gastrointestinal, cardiovascular, respiratory,
central nervous system and endocrine. These were
similar to those reported in the recent study.7 From the
3226 medications supplied under this service, 439
(13.6%) were classed as high-risk medications. Many
studies have reported medication-related reasons for
hospital admissions, with non-adherence frequently fea-
turing as a contributor.20–23 A relatively recent systematic
review of drugs causing preventable admissions to hos-
pital reported that from the 17 included studies identi-
ﬁed, diuretics, antidiabetics and antiepileptics were the
drugs associated with patient adherence problems,
Table 4 Estimated costs of OOH services if PERMSS had not been available as per patient feedback
Alternative service accessed Consultation fee Number of patients Cost (December to April) Cost per annum
GP OOH via NHS 111 £96 (GP OOH)+£8
(NHS 111 call)
30 £3120 £9360
Walk-in/urgent care centre £57 499 £28 443 £85 329
A&E (type 3)* £57 166 £9462 £28 386
Total £41 025 £123 075
*Classified as a minor department attendance.
A&E, accident and emergency; GP, general practitioner; NHS, National Health Service; OOH, out of hours; PERMSS, Pharmacy Emergency
Repeat Medication Supply Service.
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which lead to admissions.24 Consequently, the identiﬁed
high-risk medications could be associated with increased
patient safety issues, especially if doses are missed or
delayed. The responses to potential alternative actions
taken by patients in the absence of PERMSS indicated
that dose(s) would have been missed in a large propor-
tion (50%) of patients. In many cases, this might have
been clinically safe, for example, missing one dose of a
statin, or aspirin being used for secondary preventative
measures. However, for some medications, this could
have posed a signiﬁcant patient risk, for example,
antidiabetics.
Unsurprisingly, the pharmacists expressed support for
such a service to be provided within community pharma-
cies as it aligns directly with their current roles and
responsibilities. They found the remit and reimburse-
ment of the service simple and effective. They conceded
that the consultation time and workload might increase
as a consequence due to the requirement of making a
record within PharmOutcomes, but this did not appear
to diminish their commitment to providing the service.
A number of patients (46%) suggested that they
would have presented at an alternative OOH service and
therefore contributed to demand at emergency and
urgent care. Most patients in this study indicated that
they would have paid for their medicines if they had
been able to access this service but with an associated
cost. The current emergency supply regulations do
provide for such a supply where patients are required to
pay a fee, the cost of which is at the discretion of the
pharmacist. However, this is contrary to previously
reported ﬁndings which indicated that a cost would
deter patients from presenting at a pharmacy and
instead presenting where an NHS-funded supply might
be guaranteed via the issue of a prescription from an
OOH service clinician.7 However, Blumenschein et al25
found that when asked a hypothetical dichotomous
question on willingness to pay (‘yes’/‘no’) of a group
offered a pharmaceutical asthma service for free, there
was an overestimation of the real willingness to pay,
when compared with a group who actually had to pay
for the service. Therefore, further work needs to be
undertaken to explore patients’ willingness to pay for a
community pharmacy emergency supply service.
The cost comparison based on patients’ responses sug-
gested that the PERMSS, when conservatively compared
with the unit costs of alternative OOH services, offers a
more economical option to the NHS for the manage-
ment of these patients’ OOH and outside emergency
and urgent care service providers (A&E and GP OOH).
These estimations were based on a hypothetical question
posed to patients in the event that PERMSS had been
unavailable, and therefore this should be explored.
Further work is required to comprehend whether
further demand for emergency supplies exists and was
managed via the normal emergency supply procedure
and recorded as the standard operating procedures of
the respective pharmacies. Entries into PharmOutcomes
only documented the number of self-presenting patients
who were considered clinically appropriate and received
an emergency supply from the community pharmacist.
Details of those patients who were advised that a supply
could not be made but referred to another pharmacy
for stock or referred to OOH for further clinical assess-
ment by another healthcare professional were not
recorded. Therefore, further work is required to under-
stand the entire need or nature of requests for emer-
gency supply medication. No patient feedback was
recorded from those who did not receive a supply; there-
fore, global satisfaction with the service requires further
evaluation. Linking the patient feedback to the patient
consultations would allow a better understanding of
patient behaviours in relation to non-adherence and
alternative services or actions that may have been taken
in the event that no supply was made at the pharmacy.
This would allow patient risk related to non-adherence
of high-risk medications to be explored more effectively.
Morecroft et al described the ethical dilemmas often
faced by community pharmacists when requests for
emergency supplies are made. Many concerns expressed
by pharmacists were related to the potential abuse of the
service as patients could use it instead of regularly
attending their GP surgery.8 It would be interesting to
investigate if such reservations still exist among the pro-
fession since it has recently been announced that
patient Summary Care Records, an electronic patient
record derived from patients’ GP records, will be pro-
vided to community pharmacies from autumn 2015.26
This development will allow pharmacists access to previ-
ously unseen complete medication histories, allowing
them to monitor for abuse of repeat requests for emer-
gency supply medications and provide more information
for adherence monitoring. This additional safeguard
might provide the profession with the freedom and
reassurance to raise public awareness of the emergency
supply service and possibly impact on patient care-
seeking behaviour related to medication issues.
CONCLUSIONS
Community pharmacists can manage patients OOH for
requests of supplies of their repeat medications. This
service was well received by patients who self-presented
at these community pharmacies and by the pharmacists
who provided the service. The cost of this service to the
NHS would appear to be economically favourable when
compared with alternative OOH services which might
have been accessed. This service appears to be an appro-
priate response to the recent calls for emergency sup-
plies to be provided by community pharmacies in order
to reduce the burden on the wider NHS.
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Correction
Nazar H, Nazar Z, Simpson J, et al. Summative service and stakeholder evaluation of
an NHS-funded community Pharmacy Emergency Repeat Medication Supply Service
(PERMSS). BMJ Open 2016;6:e009736.
The calculation in the cost comparison paragraph on pages 5–6 is incorrect and
should be:
Of the 1511 self-presenting patients who provided feedback, 695 stated that they
would have accessed an alternative OOH service had the PERMSS not been available.
Each patient received an average of 1.58 medications, and therefore the average
PERMSS cost was £11.16. For the 695 patients, the cost in reimbursement to the com-
munity pharmacist for the consultation was estimated to be £7,756.20. The projected
annual cost of PERMSS would be £23,268.60. The estimated cost of the alternative
service access is shown in table 4.
During the evaluation period, if alternative OOH services had been accessed in
place of PERMSS, this could have been associated with an estimated cost of £41
025, 5 times the cost for supplies made via PERMSS.
As a consequence of this error the results section of the abstract should also be
changed to reﬂect this as follows:
The cost of National Health Service (NHS) service(s) for patients who would have
accessed an alternative OOH service was estimated as 5 times that of the community
pharmacy service provided.
BMJ Open 2016;6:009736corr1. doi:10.1136/bmjopen-2015-009736corr1
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